Science
Multivariant Covid vaccine booster shows promise, early data suggests
The initial phase one clinical data shows the vaccine has strong levels of neutralising antibodies
Carnivores are more prone to cancer: Study
The research was done using data on 191 species and 110,148 individual mammals
Fully vaccinated COVID-19 patients with cancer had 13 per cent mortality rate: Study
The study was conducted by the COVID-19 and Cancer Consortium (CCC19)
Omicron will soon replace Delta as dominant global variant: Experts
The new variant was first detected in South Africa on November 11, and spread across more than 110 countries
Clear data supporting very high immune escape potential of Omicron: INSACOG
India has recorded 781 cases of the Omicron variant of coronavirus across 21 states and UTs so far
Antibodies that can block Omicron variant identified
The research may help design vaccines and antibody treatments that will be effective against other variants that may emerge in future
Innovative X-ray imaging shows COVID-19 can cause vascular damage to the heart
The scientists imaged the tissue architecture to a high resolution using synchrotron radiation and displayed it three-dimensionally
Study finds why some COVID cases are more critical than others:
The study, led by Yale University's Richard Flavell, has been published in the 'Nature Biotechnology Journal'
Omicron less likely to put you in the hospital, studies say
The findings have not yet been reviewed by other experts, the gold standard in scientific research
Novavax says COVID vaccine triggers immune response to Omicron variant
Novavax said it is working on developing an Omicron-specific vaccine and expects to begin manufacturing its doses in January